 Each tablet contains oxeladin citrate 20 mg.The box contains 20 tablets in blister packs


The Drug and Medical Technology Agency of Armenia rejected the registration of oxeladin in July 2000 since studies in Germany have shown potential carcinogenicity of the drug.